https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-16 / Mol. Cancer 2015 Dec;14:210
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-16 / Mol. Cancer 2015 Dec;14:2102015-12-16 00:00:002015-12-16 00:00:00Enhanced therapeutic effect using sequential administration of antigenically distinct oncolytic viruses expressing oncostatin M in a Syrian hamster orthotopic pancreatic cancer model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-11 / Vaccines (Basel) 2015 Dec;3(4):1004-18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-11 / Vaccines (Basel) 2015 Dec;3(4):1004-182015-12-11 00:00:002019-02-15 08:39:04Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms‘ Tumor 1 in Patients with Advanced Colorectal Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-10 / Br. J. Cancer 2015 Dec;113(12):1666-76
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-10 / Br. J. Cancer 2015 Dec;113(12):1666-762015-12-10 00:00:002019-02-15 08:47:50A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-08 / J. Infect. Dis. 2016 May;213(9):1400-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-08 / J. Infect. Dis. 2016 May;213(9):1400-92015-12-08 00:00:002019-02-15 08:48:02Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-08 / Genet. Mol. Res. 2015 Dec;14(4):16222-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-08 / Genet. Mol. Res. 2015 Dec;14(4):16222-322015-12-08 00:00:002015-12-08 00:00:00Clinical research on dendritic cell vaccines to prevent postoperative recurrence and metastasis of liver cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-02 / Expert Rev Clin Immunol 2016;12(2):91-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-02 / Expert Rev Clin Immunol 2016;12(2):91-42015-12-02 00:00:002019-02-15 08:48:04HIV immunotherapy comes of age: implications for prevention, treatment and cure
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-11-15 / Am J Cancer Res 2015;5(12):3612-23
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-11-15 / Am J Cancer Res 2015;5(12):3612-232015-11-15 00:00:002015-11-15 00:00:00Oncolytic newcastle disease virus triggers cell death of lung cancer spheroids and is enhanced by pharmacological inhibition of autophagy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-11-15 / World J Gastrointest Oncol 2015 Nov;7(11):338-46
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-11-15 / World J Gastrointest Oncol 2015 Nov;7(11):338-462015-11-15 00:00:002015-11-15 00:00:00Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-11-05 / Cancer 2016 Feb;122(3):367-77
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-11-05 / Cancer 2016 Feb;122(3):367-772015-11-05 00:00:002015-11-05 00:00:00Immunotherapy in hepatocellular carcinoma: Primed to make a difference?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-11-02 / Radiother Oncol 2015 Nov;117(2):223-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-11-02 / Radiother Oncol 2015 Nov;117(2):223-82015-11-02 00:00:002015-11-02 00:00:00Reirradiation and hyperthermia for irresectable locoregional recurrent breast cancer in previously irradiated area: Size matters
